Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing countryJayastu Senapati, Tulika Seth, Ganesh Kumar Vishwanathan et al.|Leukemia & lymphoma/Leukemia and lymphoma|2021Cited by 13
Prekallikrein deficiency due to homozygous <i>KLKB1</i>(+) mutation c.444_445insT (p.Ser151PhefsTer34)Reema Miria Abraham, Manoranjan Mahapatra, Ganesh Kumar Viswanathan et al.|International Journal of Laboratory Hematology|2021Cited by 4
Shifting gears to differentiation agents in acute promyelocytic leukemia with resource constraints—a cohort studyTejasvini Vaid, Manoranjan Mahapatra, Mukul Aggarwal et al.|Acta Oncologica|2022Cited by 4
Clinical Profile, Complications and Outcomes of Patients with Acute Promyelocytic Leukemia: Indian PerspectiveTejasvini Vaid, Manoranjan Mahapatra, Tulika Seth et al.|Blood|2021Cited by 2